Cargando…
New approaches to idiopathic neutropenia in the era of clonal hematopoiesis
Isolated chronic idiopathic neutropenia (CIN) is a rare disease with multiple contributing etiologies that must be ruled out before establishing a diagnosis. We studied clinical and molecular data of 238 consecutive adult patients with CIN. Autoimmune neutropenia was present in 28% of our cohort. In...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148514/ https://www.ncbi.nlm.nih.gov/pubmed/37118760 http://dx.doi.org/10.1186/s40164-023-00403-4 |
_version_ | 1785034990603468800 |
---|---|
author | Ogbue, Olisaemeka D. Kewan, Tariq Bahaj, Waled S. Gurnari, Carmelo Visconte, Valeria Maciejewski, Jaroslaw P. |
author_facet | Ogbue, Olisaemeka D. Kewan, Tariq Bahaj, Waled S. Gurnari, Carmelo Visconte, Valeria Maciejewski, Jaroslaw P. |
author_sort | Ogbue, Olisaemeka D. |
collection | PubMed |
description | Isolated chronic idiopathic neutropenia (CIN) is a rare disease with multiple contributing etiologies that must be ruled out before establishing a diagnosis. We studied clinical and molecular data of 238 consecutive adult patients with CIN. Autoimmune neutropenia was present in 28% of our cohort. In contrast, T cell-mediated neutropenia was the main underlying pathological mechanism among patients with T cell expansions, such as T-cell large granular lymphocytic leukemia (T-LGL) and T cell clonopathy of undetermined significance, found in 37% and 8% of cases, respectively. Patients with neutropenia also had hypogammaglobulinemia (6%) and/or monoclonal gammopathy of undetermined significance (5%). NGS application has further broadened the spectrum of causes of CIN by including manifestations of clonal hematopoiesis, present in 12% of cases. TET2 (3%), TP53 (2%), and IDH1/IDH2 (2%) mutations were the most commonly found and were enriched in cases with T-LGL. We show that these clinico-molecular associations can be simultaneously present, complicating a proper diagnostic distinction within the broader entity of seemingly idiopathic neutropenia of autoimmune origin. Identification of etiologic culprits may also guide rational selection of therapies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40164-023-00403-4. |
format | Online Article Text |
id | pubmed-10148514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101485142023-04-30 New approaches to idiopathic neutropenia in the era of clonal hematopoiesis Ogbue, Olisaemeka D. Kewan, Tariq Bahaj, Waled S. Gurnari, Carmelo Visconte, Valeria Maciejewski, Jaroslaw P. Exp Hematol Oncol Correspondence Isolated chronic idiopathic neutropenia (CIN) is a rare disease with multiple contributing etiologies that must be ruled out before establishing a diagnosis. We studied clinical and molecular data of 238 consecutive adult patients with CIN. Autoimmune neutropenia was present in 28% of our cohort. In contrast, T cell-mediated neutropenia was the main underlying pathological mechanism among patients with T cell expansions, such as T-cell large granular lymphocytic leukemia (T-LGL) and T cell clonopathy of undetermined significance, found in 37% and 8% of cases, respectively. Patients with neutropenia also had hypogammaglobulinemia (6%) and/or monoclonal gammopathy of undetermined significance (5%). NGS application has further broadened the spectrum of causes of CIN by including manifestations of clonal hematopoiesis, present in 12% of cases. TET2 (3%), TP53 (2%), and IDH1/IDH2 (2%) mutations were the most commonly found and were enriched in cases with T-LGL. We show that these clinico-molecular associations can be simultaneously present, complicating a proper diagnostic distinction within the broader entity of seemingly idiopathic neutropenia of autoimmune origin. Identification of etiologic culprits may also guide rational selection of therapies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40164-023-00403-4. BioMed Central 2023-04-28 /pmc/articles/PMC10148514/ /pubmed/37118760 http://dx.doi.org/10.1186/s40164-023-00403-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correspondence Ogbue, Olisaemeka D. Kewan, Tariq Bahaj, Waled S. Gurnari, Carmelo Visconte, Valeria Maciejewski, Jaroslaw P. New approaches to idiopathic neutropenia in the era of clonal hematopoiesis |
title | New approaches to idiopathic neutropenia in the era of clonal hematopoiesis |
title_full | New approaches to idiopathic neutropenia in the era of clonal hematopoiesis |
title_fullStr | New approaches to idiopathic neutropenia in the era of clonal hematopoiesis |
title_full_unstemmed | New approaches to idiopathic neutropenia in the era of clonal hematopoiesis |
title_short | New approaches to idiopathic neutropenia in the era of clonal hematopoiesis |
title_sort | new approaches to idiopathic neutropenia in the era of clonal hematopoiesis |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148514/ https://www.ncbi.nlm.nih.gov/pubmed/37118760 http://dx.doi.org/10.1186/s40164-023-00403-4 |
work_keys_str_mv | AT ogbueolisaemekad newapproachestoidiopathicneutropeniaintheeraofclonalhematopoiesis AT kewantariq newapproachestoidiopathicneutropeniaintheeraofclonalhematopoiesis AT bahajwaleds newapproachestoidiopathicneutropeniaintheeraofclonalhematopoiesis AT gurnaricarmelo newapproachestoidiopathicneutropeniaintheeraofclonalhematopoiesis AT viscontevaleria newapproachestoidiopathicneutropeniaintheeraofclonalhematopoiesis AT maciejewskijaroslawp newapproachestoidiopathicneutropeniaintheeraofclonalhematopoiesis |